Article Text

Download PDFPDF
Vitamin D and autoimmunity: new aetiological and therapeutic considerations
  1. Yoav Arnson1,
  2. Howard Amital1,
  3. Yehuda Shoenfeld2
  1. 1Department of Medicine ‘D’, Meir Medical Center, Kfar-Saba, affiliated to Tel-Aviv University Sackler Faculty of Medicine, Israel
  2. 2Department of Medicine ‘B’ and Center for Autoimmune Diseases, affiliated to Tel-Aviv University Sackler Faculty of Medicine, Sheba Medical Center, Tel-Hashomer, Israel
  1. Correspondence to:
    Dr Howard Amital
    Head of Department of Medicine ‘D’, Meir Medical Center, Tshernichovsky 59, Kfar-Saba, 95847, Israel;hamital{at}netvision.net.il

Abstract

Vitamin D is frequently prescribed by rheumatologists to prevent and treat osteoporosis. Several observations have shown that vitamin D inhibits proinflammatory processes by suppressing the enhanced activity of immune cells that take part in the autoimmune reaction. Moreover, recent evidence strongly suggests that vitamin D supplementation may be therapeutically beneficial, particularly for Th1-mediated autoimmune disorders. Some reports imply that vitamin D may even be preventive in certain disorders such as multiple sclerosis and diabetes type 1. It seems that vitamin D has crossed the boundaries of calcium metabolism and has become a significant factor in a number of physiological functions, specifically as a biological inhibitor of inflammatory hyperactivity.

  • 1,25(OH)2D3, 1,25-dihydroxyvitamin D3
  • 25(OH)D, 25-hydroxyvitamin D
  • GM-CSF, granulocyte-macrophage colony stimulating factor
  • IFNγ, interferon γ
  • IL, interleukin
  • NFκB, nuclear factor κB
  • SLE, systemic lupus erythematosus
  • VDR, vitamin D receptor

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Published Online First 8 June 2007

  • Competing interests: None.